THEOFAN GEORGIA 4
4 · IMMUNE RESPONSE CORP · Filed Apr 8, 2005
Insider Transaction Report
Form 4
THEOFAN GEORGIA
VP, Clinical Development
Transactions
- Award
Common Stock
2005-03-31$0.78/sh+3,926$3,062→ 18,855 total
Footnotes (1)
- [F1]Matching company contribution to 401K account.